Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-21
SponsorUniversity of Michigan

About this trial

The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children with Hypotonic Upper Airway Obstruction (HUAO): This includes those who newly diagnosed with obstructive sleep apnea (OSA). These children will undergo overnight polysomnography to determine the presence of OSA (apnea-hypopnea index [AHI]>10 or AHI>5 with nocturnal hypoxemia defined as oxygen saturation by pulse oximetry [SpO2] nadir <=75%).

All subjects require the presence of at least one symptom of OSA (such as snoring 3 or more nights per week, daytime sleepiness, or hyperactive/inattentive behaviors)

Post adenotonsillectomy or those with contraindications to tonsillectomy.

Tonsil size 2+ or smaller.

Disqualifiers

AHI ≤10 on polysomnogram (PSG) without hypoxemia or AHI<5 with hypoxemia.

Any medical reason why Self-Supporting Nasopharyngeal Airway (ssNPA) therapy may not be suitable

Active Coronavirus (COVID) 19 infections

End-tidal carbon dioxide (ETCO2) or Transcutaneous carbon dioxide (TCO2) values >60 mmHg for >10% of sleep time on PSG

Trial design

Design model

Parallel

Treatments tested in this trial

  • Self-Supporting Nasopharyngeal Airway (ssNPA)

    Device

    The ssNPA device is made of a single piece of flexible, medical-grade silicone. It is inserted through one nostril and extends to the anatomic position bypassing the upper airway obstruction above the epiglottis.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Self-Supporting Nasopharyngeal Airway (ssNPA)Experimental treatment 1 intervention
Group B: Standard of CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Apnea-hypopnea index (AHI)

Measured during the polysomnogram

Time frame
Up to 16 weeks
2

Self-Supporting Nasopharyngeal Airway (ssNPA) tolerance

Measured by self report. Likert scale 0-5 (higher score is better)

Time frame
Up to 16 weeks

Secondary outcomes

1

Sleep quality

Higher score in parent report of sleep quality on scale 0-5 (higher score is better)

Time frame
Up to 16 weeks
2

Snoring frequency

As reported by participant/care taker in survey given daily. Snoring frequency is rated on a Likert scale 1-5 where 5 indicates snoring more frequently.

Time frame
Up to 16 weeks
3

Daytime sleepiness

Measured using the children's Epworth Sleepiness Scale - The Epworth Sleepiness Scale is a self-administered form with eight items investigating sleep propensity in different real-life situations during the preceding months. Each item can received 0-3 points, thus the final score ranges from 0 (best score) to 24 (worse score).

Time frame
Up to 16 weeks
4

Quality of life as indicated by the dimensions of the PedsQL (pediatric quality of life) instrument.

There are several dimensions of the PedsQL: Physical Functioning, Emotional Functioning, Social Functioning and School Functioning. Each domain will be scored on a scale of 0 (never have problems) to 4 (almost always have problems) and transformed on a scale of 0-100 by reverse scoring (0=100, 1=75, 2=50, 3=25, 4=0). Psychosocial Health Summary Score is the sum of the items over the number of items answered in the Emotional, Social, and School Functioning scales. Physical Health Summary Score is the Physical Functioning Scale Score. The total quality of life score is the sum of all the items over the number of items answered on all scales.

Time frame
Up to 16 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Michigan

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator